Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Guardant Health, Inc. (GH)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 121,380,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Guardant Health is a precision oncology company focused on helping conquer cancer globally through use of its proprietary blood-based tests, data sets and analytics. Co. is engaged in the clinical liquid biopsy market with its Guardant360 and GuardantOMNI tests. Co.'s Guardant360 test is a molecular diagnostic test measuring a number of cancer-related genes and its GuardantOMNI test has a 500-gene panel, both of which analyze circulating tumor DNA in blood. In addition, Co. is developing tests from its LUNAR-1 program for minimal residual disease and recurrence detection in cancer survivors, and its LUNAR-2 program for early detection of cancer.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 2,187 2,187 98,220
Total Buy Value $0 $38,963 $38,963 $2,585,297
Total People Bought 0 1 1 2
Total Buy Transactions 0 1 1 4
Total Shares Sold 100 200 8,325 31,716
Total Sell Value $2,787 $4,692 $233,035 $1,293,892
Total People Sold 1 1 2 3
Total Sell Transactions 1 2 6 12
End Date 2024-03-24 2023-12-22 2023-06-23 2022-06-23

   
Records found: 707
  Page 13 of 29  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Eltoukhy Helmy Chief Executive Officer   •       •      –    2021-04-20 4 AS $148.10 $2,413,000 D/D (16,007) 1,892,260     -
   Eltoukhy Helmy Chief Executive Officer   •       •      –    2021-04-19 4 AS $151.17 $7,790,914 D/D (50,932) 1,908,267     -
   Eltoukhy Helmy Chief Executive Officer   •       •      –    2021-04-16 4 AS $157.09 $8,094,721 D/D (51,123) 1,959,199     -
   Eltoukhy Helmy Chief Executive Officer   •       •      –    2021-04-15 4 AS $156.67 $24,957,096 D/D (157,107) 2,010,322     -
   Saia John G. See Remarks   •       –      –    2021-04-15 4 D $159.20 $171,458 D/D (1,077) 14,826     -
   Eltoukhy Helmy Chief Executive Officer   •       •      –    2021-04-14 4 AS $154.49 $9,545,874 D/D (60,982) 2,167,429     -
   Eltoukhy Helmy Chief Executive Officer   •       •      –    2021-04-13 4 AS $153.78 $16,581,445 D/D (105,806) 2,228,411     -
   Eltoukhy Helmy Chief Executive Officer   •       •      –    2021-04-12 4 AS $151.80 $11,263,846 D/D (72,861) 2,334,217     -
   Meresman Stanley J Director   –       •      –    2021-04-12 4 AS $151.91 $758,533 D/D (4,934) 4,059     -
   Meresman Stanley J Director   –       •      –    2021-04-12 4 OE $5.94 $29,308 D/D 4,934 8,993     -
   Eltoukhy Helmy Chief Executive Officer   •       •      –    2021-04-09 4 AS $155.89 $9,567,678 D/D (60,996) 2,407,078     -
   Eltoukhy Helmy Chief Executive Officer   •       •      –    2021-04-08 4 AS $159.48 $19,751,186 D/D (122,846) 2,468,074     -
   Eltoukhy Helmy Chief Executive Officer   •       •      –    2021-04-07 4 AS $156.75 $5,843,684 D/D (36,843) 2,590,920     -
   Kaul Samir Director   –       •      –    2021-04-05 4 AS $155.91 $792,789 I/I (5,000) 19,943     -
   Clark Ian T Director   –       •      –    2021-03-25 4 AS $132.09 $71,064 D/D (538) 4,643     -
   Clark Ian T Director   –       •      –    2021-03-25 4 OE $4.18 $2,249 D/D 538 5,181     -
   Meresman Stanley J Director   –       •      –    2021-03-10 4 AS $137.85 $680,152 D/D (4,934) 4,059     -
   Meresman Stanley J Director   –       •      –    2021-03-10 4 OE $5.94 $29,308 D/D 4,934 8,993     -
   Clark Ian T Director   –       •      –    2021-02-25 4 AS $154.00 $82,852 D/D (538) 4,643     -
   Clark Ian T Director   –       •      –    2021-02-25 4 OE $4.18 $2,249 D/D 538 5,181     -
   Talasaz Amirali Chairman, President and COO   •       •      –    2021-02-11 4 AS $168.35 $1,114,042 I/I (6,613) 470,800     -
   Talasaz Amirali Chairman, President and COO   •       •      –    2021-02-11 4 AS $162.81 $3,918,993 I/I (23,529) 477,413     -
   Talasaz Amirali Chairman, President and COO   •       •      –    2021-02-11 4 AS $162.65 $33,771,358 D/D (202,251) 1,725,422     -
   Meresman Stanley J Director   –       •      –    2021-02-10 4 AS $162.71 $802,811 D/D (4,934) 4,059     -
   Meresman Stanley J Director   –       •      –    2021-02-10 4 OE $5.94 $29,308 D/D 4,934 8,993     -

  707 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 13 of 29
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed